DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
DIROCAFTOR
1
Small molecule
Investigational
Unknown
Unknown
Cystic Fibrosis
Unknown
DIROCAFTOR
×
Maximum Phase:
1
First Approval:
None
UNII:
2G3T6M1AS9
Molecule Type:
Small molecule
Molecular Formula:
C22H28N2O3Si2
Molecular Weight:
424.65
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PINOMETOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Unknown
PINOMETOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
8V9YR09EF3
Molecule Type:
Small molecule
Molecular Formula:
C30H42N8O3
Molecular Weight:
562.72
AlogP:
3.32
PSA:
151.23
HBD:
4.0
HBA:
#RotB:
8.0
Source:
CORDYCEPIN
1
Small molecule
Investigational
Unknown
Unknown
Leukemia
Unknown
CORDYCEPIN
×
Maximum Phase:
1
First Approval:
None
UNII:
GZ8VF4M2J8
Molecule Type:
Small molecule
Molecular Formula:
C10H13N5O3
Molecular Weight:
251.25
AlogP:
-0.95
PSA:
119.31
HBD:
3.0
HBA:
#RotB:
2.0
Source:
ENADENOTUCIREV
1
Unknown
Investigational
Unknown
Unknown
Ovarian Neoplasms; Rectal Neoplasms
Unknown
ENADENOTUCIREV
×
Maximum Phase:
1
First Approval:
None
UNII:
KX7ZYR6OQW
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ATAMPARIB
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
ATAMPARIB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-06863135
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
PF-06863135
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMG-427
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
AMG-427
×
Maximum Phase:
1
First Approval:
None
UNII:
P9I9Z3MF7Z
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GS-9901
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular
Unknown
GS-9901
×
Maximum Phase:
1
First Approval:
None
UNII:
U09Q76B8VK
Molecule Type:
Small molecule
Molecular Formula:
C22H17ClFN9O
Molecular Weight:
477.89
AlogP:
2.96
PSA:
161.42
HBD:
3.0
HBA:
#RotB:
5.0
Source:
GSK2879552
1
Small molecule
Investigational
Unknown
Unknown
Leukemia; Myelodysplastic Syndromes; Small Cell Lung Carcinoma
Unknown
GSK2879552
×
Maximum Phase:
1
First Approval:
None
UNII:
GT77Z6Y09Z
Molecule Type:
Small molecule
Molecular Formula:
C23H28N2O2
Molecular Weight:
364.49
AlogP:
3.74
PSA:
52.57
HBD:
2.0
HBA:
#RotB:
7.0
Source:
MK-8325
1
Unknown
Investigational
Unknown
Unknown
Hepatitis C, Chronic
Unknown
MK-8325
×
Maximum Phase:
1
First Approval:
None
UNII:
779TT17O5A
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GS-9191
1
Small molecule
Investigational
Unknown
Unknown
Condylomata Acuminata
Unknown
GS-9191
×
Maximum Phase:
1
First Approval:
None
UNII:
5I2GJW5Z2Q
Molecule Type:
Small molecule
Molecular Formula:
C37H51N8O6P
Molecular Weight:
734.84
AlogP:
4.95
PSA:
184.61
HBD:
4.0
HBA:
#RotB:
21.0
Source:
THIAMPHENICOL
1
Small molecule
Investigational
Unknown
Unknown
Bacterial Infections
Unknown
THIAMPHENICOL
×
Maximum Phase:
1
First Approval:
None
UNII:
FLQ7571NPM
Molecule Type:
Small molecule
Molecular Formula:
C12H15Cl2NO5S
Molecular Weight:
356.23
AlogP:
0.4
PSA:
103.7
HBD:
3.0
HBA:
#RotB:
6.0
Source:
BTI-410
1
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
BTI-410
×
Maximum Phase:
1
First Approval:
None
UNII:
D5DS571AIS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ON123300
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
ON123300
×
Maximum Phase:
1
First Approval:
None
UNII:
QJ8RO3296G
Molecule Type:
Small molecule
Molecular Formula:
C24H27N7O
Molecular Weight:
429.53
AlogP:
3.27
PSA:
90.08
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SIRPIGLENASTAT
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SIRPIGLENASTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C22H27N5O5
Molecular Weight:
441.49
AlogP:
1.3
PSA:
153.76
HBD:
3.0
HBA:
#RotB:
11.0
Source:
MP-0250
1
Unknown
Investigational
Unknown
Unknown
Multiple Myeloma; Neoplasms
Unknown
MP-0250
×
Maximum Phase:
1
First Approval:
None
UNII:
UGI01OSA4N
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AV0113 DC-CIT
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AV0113 DC-CIT
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LBS-008
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LBS-008
×
Maximum Phase:
1
First Approval:
None
UNII:
63WI9S8P1M
Molecule Type:
Small molecule
Molecular Formula:
C21H21F5N4O2
Molecular Weight:
456.42
AlogP:
3.63
PSA:
69.3
HBD:
1.0
HBA:
#RotB:
2.0
Source:
F-18-ISO
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
F-18-ISO
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LY-3009120
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Melanoma; Neoplasm Metastasis
Serine/threonine-protein kinase A-Raf inhibitor
LY-3009120
×
Maximum Phase:
1
First Approval:
None
UNII:
1GDT36RARO
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IODOMETOMIDATE I-123, R-
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
IODOMETOMIDATE I-123, R-
×
Maximum Phase:
1
First Approval:
None
UNII:
U21CVV13SV
Molecule Type:
Small molecule
Molecular Formula:
C13H13IN2O2
Molecular Weight:
356.16
AlogP:
2.88
PSA:
44.12
HBD:
0.0
HBA:
#RotB:
3.0
Source:
177LU-ST2210
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
177LU-ST2210
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
YTTRIUM Y 90 EPRATUZUMAB
1
Antibody
Investigational
Unknown
Unknown
Unknown
CD22 binding agent
YTTRIUM Y 90 EPRATUZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-06273340
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PF-06273340
×
Maximum Phase:
1
First Approval:
None
UNII:
I136775ABW
Molecule Type:
Small molecule
Molecular Formula:
C23H22ClN7O3
Molecular Weight:
479.93
AlogP:
2.6
PSA:
148.91
HBD:
3.0
HBA:
#RotB:
7.0
Source:
MK-6186
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
MK-6186
×
Maximum Phase:
1
First Approval:
None
UNII:
K3978U665M
Molecule Type:
Small molecule
Molecular Formula:
C21H12Cl2N6O
Molecular Weight:
435.27
AlogP:
5.33
PSA:
92.41
HBD:
1.0
HBA:
#RotB:
4.0
Source:
AZD-4769
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Epidermal growth factor receptor erbB1 inhibitor
AZD-4769
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C28H27NO3S
Molecular Weight:
457.6
AlogP:
6.7
PSA:
59.42
HBD:
1.0
HBA:
#RotB:
11.0
Source:
MURIZATOCLAX
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Multiple Myeloma; Myelodysplastic Syndromes
Unknown
MURIZATOCLAX
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C42H57ClN4O5S
Molecular Weight:
765.46
AlogP:
6.44
PSA:
91.42
HBD:
1.0
HBA:
#RotB:
3.0
Source:
RUNIMOTAMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
RUNIMOTAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEDI-4276
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
MEDI-4276
×
Maximum Phase:
1
First Approval:
None
UNII:
ZAM3L34SEW
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LGX-806
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Serine/threonine-protein kinase B-raf inhibitor
LGX-806
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
2-DEOXY-D-GLUCOSE
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
2-DEOXY-D-GLUCOSE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C6H12O5
Molecular Weight:
164.16
AlogP:
-2.19
PSA:
90.15
HBD:
4.0
HBA:
#RotB:
1.0
Source:
KB-004
1
Antibody
Investigational
Unknown
Unknown
Glioblastoma; Myelodysplastic Syndromes; Primary Myelofibrosis
Ephrin type-A receptor 3 inhibitor
KB-004
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RG-7594
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
RG-7594
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DOTAMTATE PB-212
1
Unknown
Investigational
Unknown
Unknown
Neuroendocrine Tumors
Unknown
DOTAMTATE PB-212
×
Maximum Phase:
1
First Approval:
None
UNII:
E9N7QV53AK
Molecule Type:
Unknown
Molecular Formula:
C65H91N17O16PbS2
Molecular Weight:
1642.67
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CYC065
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
CYC065
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
106
107
108
109
110
111
112
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA